Myriad Genetics Offers Many Types of Molecular Tests Its top seller is the MyRisk Hereditary cancer test, which evaluates 48 genes to help identify a patient's risk of developing 11 different ...

Myriad Genetics, Inc. announced that its MyRisk® Hereditary Cancer Test with RiskScore® was recognized in the American Journal of Human Genetics as one of the top 10 significant advances in ...

Clinicians reported enhanced confidence in hereditary cancer risk assessment practices, with many expressing intentions to continue using the program. Myriad Genetics emphasizes its commitment to ...

Myriad Genetics (MYGN) announced a study revealing that more patients completed hereditary cancer testing when they used an online screening tool and received education about genetic testing.

“Hereditary cancer risk assessment may provide ... For more information, visit www.gabbi.com. About Myriad Genetics Myriad Genetics is a leading molecular diagnostic testing and precision ...

Myriad Genetics started out as the monopoly in hereditary breast cancer diagnostics. Its oldest test was BRACAnalysis, a predictive test for mutations tied to an increased risk of hereditary ...

Not so for Myriad Genetics. A change in billing codes commonly used for its hereditary cancer tests, originally expected to have an immaterial impact on the business in fiscal 2020, is now ...

Myriad Genetics reported fourth quarter earnings ... ("YoY") and EPS of $0.36 missed by a couple cents. Myriad's core hereditary cancer testing generated 82% of total revenue in the quarter ...

Morningstar brands and products Company Portfolio ...

Myriad Genetics has delivered on its diversification promise, thanks to savvy deals, creating real diversification from its core hereditary cancer test franchise. I like the progress being made ...